Have a personal or library account? Click to login
Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy? Cover

Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy?

Open Access
|Dec 2019

References

  1. [1] Martin J, Barras M, Ah Yui N, Kirkpatrick C, Kubler P, No R: Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. J Clinic Toxicol. 2012;2(8):1–5.10.4172/2161-0495.1000146
  2. [2] Durante-Mangoni E, Grammaticos A, Utili R, Falagas ME: Do we still need the aminoglycosides? Int J Antimicrob Agents. 2009;33(3):201–205.10.1016/j.ijantimicag.2008.09.00118976888
  3. [3] Gómolka M, Niemczyk S: How to safely and effectively administer aminoglycoside antibiotics. Pol. Merkur. Lekarski. 2014;36(214):225–228.
  4. [4] Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect. 2010;11:79–109.10.1089/sur.2009.993020163262
  5. [5] Thomson AH, Duncan N, Silverstein B, Alcock S, Jodrell D: Development of gudelines for gentamicin dosing. J Antimicrob Chemother. 1996;38(5):885–893.10.1093/jac/38.5.8858961061
  6. [6] Cox ZL, Nelsen CL, Waitman LR, McCoy JA, Peterson JF: Clinical Decision Support Improves Initial Dosing and Monitoring of Tobramycin and Amikacin. American Society of Health-System Pharmacist. 2011;68(7): 624–632.10.2146/ajhp100155306037921411805
  7. [7] Fonzo-Christie C, Guignard B, Zaugg C et al.: Impact of clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns. Ther Drug Monit. 2014;36(5):656–662.10.1097/FTD.000000000000007124690586
  8. [8] Barza M, Ioannidis JP, Cappelleri JC, Lau J et al.: Single and multiple daily doses of aminoglycosides a meta-analysis. BMJ. 1996;10(312):338–345.10.1136/bmj.312.7027.33823502898611830
  9. [9] Nezic L, Derungs A, Bruggisser M, Tschudin-Sutter S, Krähenbühl S, Haschke M: Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy. Eur J Clin Pharmacol. 2014;70(7):829–837.10.1007/s00228-014-1680-324756148
  10. [10] Radigan EA, Gilchrist NA, Miller MA: Managment of aminoglycosides in the intensive care unit. J Intensive Care Med. 2010;26(6):327–342.10.1177/088506661037796820837630
  11. [11] Wong G, Sime FB, Lipman, J, Roberts JA: How do we use therapeutic drug monitoring to improve outcome from severe infections in critically ill patients? BMC Infect Dis. 2014;14:288.10.1186/1471-2334-14-288428921125430961
Language: English
Page range: 11 - 18
Submitted on: Sep 24, 2018
Accepted on: Jan 11, 2019
Published on: Dec 26, 2019
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2019 M. Göböová, I. Vaňo, V. Kissová, T. Fazekaš, M. Kuželová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.